From Maastricht University Medical Center+, Maastricht, Limburg, the Netherlands (van Amelsfort, Webers); Maastricht University Hospital, Maastricht Universitair Medisch Centrum+. Maastricht, the Netherlands (Bauer, Clement, van den Biggelaar, Nuijts).
J Cataract Refract Surg. 2022 Feb 1;48(2):151-156. doi: 10.1097/j.jcrs.0000000000000825.
To evaluate visual outcomes, spectacle independence, and optical phenomena after bilateral implantation of a nondiffractive extended depth-of-focus (EDoF) intraocular lens (IOL) targeted for minimonovision.
University Eye Clinic Maastricht, the Netherlands.
Prospective case series.
Patients with age-related cataract were bilaterally implanted with a nondiffractive EDoF IOL (Alcon AcrySof IQ Vivity), targeted for minimonovision. Outcome measures were the uncorrected distance visual acuity (UDVA), corrected distance visual acuity, uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA), distance corrected intermediate visual acuity, distance corrected near visual acuity, refractive outcomes, defocus curves, spectacle independence, photic phenomena, and Catquest-9SF questionnaire.
44 eyes of 22 patients were included. The mean binocular UDVA, UIVA, and UNVA were -0.07 (±0.10), 0.04 (±0.09), and 0.23 (±0.12) logMAR, respectively. The percentage of eyes within ±1.0 diopters (D) and ±0.5 D of target was 100% and 95% for the dominant eye and 100% and 86% for the nondominant eye, respectively. The binocular defocus curve was better than 0.10 logMAR over a range from -2.0 D to +0.5 D. The percentage of patients who reported not or rarely using spectacles for distance, intermediate, and near viewing distance was 96%, 68%, and 38%, respectively. The percentage of patients who experienced no halos, glare, or starbursts were 91%, 91%, and 100%, respectively. The Catquest-9SF showed a high patient satisfaction for daily life activities.
Bilateral AcrySof IQ Vivity IOL implantation targeted for minimonovision provided good visual acuity results for far and intermediate with functional near vision, high level of patient satisfaction and spectacle independence, and a monofocal disturbance profile.
评估双眼植入非衍射扩展景深（EDoF）人工晶状体（IOL）后用于最小单视的视觉结果、不依赖眼镜的程度和光学现象。
荷兰马斯特里赫特大学眼科诊所。
前瞻性病例系列。
患有年龄相关性白内障的患者双眼植入非衍射 EDoF IOL（Alcon AcrySof IQ Vivity），目标为最小单视。主要观察指标为未矫正远视力（UDVA）、矫正远视力、未矫正中间视力（UIVA）、未矫正近视力（UNVA）、远距矫正中间视力、远距矫正近视力、屈光结果、散焦曲线、不依赖眼镜的程度、光学现象和 Catquest-9SF 问卷。
共纳入 22 例（44 只眼）患者。双眼平均 UDVA、UIVA 和 UNVA 分别为-0.07（±0.10）、0.04（±0.09）和 0.23（±0.12）logMAR。主导眼和非主导眼的±1.0 屈光度（D）和±0.5 D 的目标眼比例分别为 100%和 95%，100%和 86%。双眼散焦曲线在-2.0 D 至+0.5 D 范围内优于 0.10 logMAR。不使用或很少使用眼镜进行远距离、中距离和近距离阅读的患者比例分别为 96%、68%和 38%。无晕影、眩光或星爆的患者比例分别为 91%、91%和 100%。Catquest-9SF 显示患者对日常生活活动的满意度很高。
双眼植入 AcrySof IQ Vivity IOL 用于最小单视，为远距和中距提供了良好的视力结果，具有功能性近视力，患者满意度高，不依赖眼镜，且具有单焦点干扰特征。
